Approval · Notice of Compliance 2858 · 2003
NOVANTRONE: Notice of Compliance 2858
Issued April 2, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2858
- Date
- April 2, 2003
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NOVANTRONE | 02173468 | Cancelled Post Market |
Medicinal ingredients
- MITOXANTRONE HYDROCHLORIDE 2 MG per ML